På denne side bringer DANSK BIOTEK nyheder fra medlemmerne, som på denne måde får mulighed for at blive ekstra eksponeret.

Vi modtager derfor gerne pressemeddelelser og andre nyheder. Send dem til Dorte Dannemann, hjælp af denne formular.

30 Sep 2014

DANSK BIOTEK indsender høringssvar til EU kommissionen

DANSK BIOTEK’s response focuses on the proposed new regime regarding non-controlling minority shareholdings and the consequences hereof on availability of corporate venture capital for developing biotech companies.

DANSK BIOTEK recommends that the EU Merger Regulation (“EUMR”) regime is not amended as proposed in the White Paper.

A notification requirement as suggested for acquisition of non-controlling minority shareholdings would generate additional restraints on biotech companies abilities to attract corporate venture capital, which is crucial to maintaining a global leverage in the field, especial amongst emerging European biotech companies.

Furthermore, the Commission already has the power to investigate most if not all structural links under Article 101 TFEU and Article 102 TFEU.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2014 Danskbiotek. All rights reserved.